iFEROL

iFEROL is an R&D project developed by Laboratorios Farmalan in collaboration with Faes Farma, focused on the development of new pharmaceutical formulations or analogues based on calcifediol (25-hydroxyvitamin D3). The project aims to address vitamin D deficiency and its associated pathologies, including cardiovascular conditions and autoimmune diseases. iFEROL leverages the immunomodulatory properties of vitamin D, acting through the Vitamin D Receptor (VDR) to regulate gene expression involved in calcium homeostasis and immune system modulation. It is currently in advanced development stages, targeting both traditional deficiency and broader immunomodulatory indications.

Other names

vitamin D analogue projectcalcifediol formulation project